Next Article in Journal
Organic Optoelectronic Materials (Volume II)
Next Article in Special Issue
Impact of Impurities on Crystallization and Product Quality: A Case Study with Paracetamol
Previous Article in Journal
Microdiamonds in Alkalic Dolerites from the North China Craton: FTIR and C Isotopic Characteristics
Previous Article in Special Issue
Ultrasound in Continuous Tubular Crystallizers: Parameters Affecting the Nucleation Rate
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Crystallization of Active Pharmaceutical Ingredients with Low Melting Points in the Presence of Liquid–Liquid Phase Separation

1
Department of Chemical & Biomolecular Engineering, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260, Singapore
2
Institute of Chemical & Engineering Sciences Ltd., A*STAR (Agency for Science, Technology and Research), 1 Pesek Road, Jurong Island, Singapore 627833, Singapore
*
Author to whom correspondence should be addressed.
Submission received: 7 October 2021 / Revised: 26 October 2021 / Accepted: 29 October 2021 / Published: 30 October 2021
(This article belongs to the Special Issue Pharmaceutical Crystallization)

Abstract

:
Liquid–liquid phase separation (LLPS) during the crystallization of active pharmaceutical ingredients (APIs) often causes agglomeration and other quality issues in crystal products; thus, it should be avoided if possible. However, LLPS in the crystallization of APIs with low melting points cannot be circumvented in some cases due to yield considerations. The crystallization of ibuprofen in an ethanol/water mixture was studied to explore methods to reduce agglomeration in the presence of LLPS. It was found that unseeded crystallization produced agglomerates when LLPS took place. The two liquid phases resulting from LLPS underwent LLPS again when they were cooled separately, indicating the dynamic nature of LLPS. Seeding and seed ageing at a low supersaturation were very effective in mitigating agglomeration. The effects of two widely used surfactants, i.e., Tween 80 and hydroxypropyl methylcellulose (HPMC), on LLPS and crystallization were confirmed preliminarily. More work needs to be conducted to explore their usefulness in LLPS handling. The findings and techniques presented in this study may be applicable to the crystallization of other APIs with low melting points.

1. Introduction

Crystallization defines the quality attributes of small-molecule active pharmaceutical ingredients (APIs), including purity, polymorphism, particle size distribution, crystal shape and morphology, etc. These quality attributes must be tightly controlled as they have impacts either on the therapeutic effects of pharmaceutical products or on the process performance in downstream units such as filtration, drying, blending with excipients and tableting. The occurrence of liquid–liquid phase separation (LLPS), or ‘oiling out’, has complicated the quality control of an increasing number of APIs. Although some APIs ‘melt’ and turn into oil droplets during dissolution in hot solvents, other APIs can dissolve normally in hot solvents but undergo LLPS during cooling or anti-solvent addition. LLPS is often associated with impeded spontaneous nucleation, excessively long batch times, ‘desert rose’ morphology and ineffective impurity rejection.
Due to its detrimental effects on the quality attributes of crystals, various strategies have been adopted to avoid LLPS [1], including lowering the starting concentration and impurity levels, solvent switching, seeding and supersaturation control [2,3], and ultrasound application [4,5]. However, many APIs exhibiting LLPS have relatively low melting points, e.g., idebenone (52.0–55.0 °C) [6], pyraclostrobin (63.7–65.2 °C) [7], butylparaben (68.5 °C) [8], ibuprofen (75.0–77.0 °C) [9], and vanillin (81.0–83.0 °C) [10]. The liquid–liquid equilibrium region in their phase diagrams is easily accessible under usual crystallization conditions. As a result, LLPS cannot be circumvented in their crystallization due to yield considerations.
Several studies have been published on crystallization in the presence of LLPS, focusing on polymorph control [7], morphological modification [8], and solvent inclusion in crystal products [11]. Seeding was employed in these studies to facilitate crystallization. Seeds provide surfaces on which solute molecules can deposit at a relatively low supersaturation [12]. During seed growth, oil droplets serve as a reservoir of solute [13]. At the same time, oil droplets also act as bridging agents for agglomeration, a possible cause of solvent inclusion and incomplete impurity rejection. This paper aims to test the hypothesis that agglomeration that happens in the presence of LLPS can be mitigated by adjusting seed loadings and cooling profiles. Using ibuprofen as the model compound, the effects of seeding and cooling profiles on crystal agglomeration will be investigated during the crystallization of APIs with relatively low melting points. In addition, many studies have demonstrated that surfactants affect nucleation and crystal growth. Their effects on LLPS and subsequent crystallization has not been reported. The effects of two widely used surfactants, Tween 80 and hydroxypropyl methylcellulose (HPMC), on LLPS and the crystallization of ibuprofen will be studied.
This paper is organized as follows: A general phase diagram will be presented in the next section to explain a few features that are relevant to crystallization and LLPS. Following it is a description of the experimental methods and procedures. Then, a kinetic phase diagram of ibuprofen in a water–ethanol mixture (50/50 v/v) will be displayed, followed by results and discussions on the effects of seeding, cooling profiles and the use of surfactant. The conclusions will be made in the last section.

2. A Generalized Phase Diagram with LLPS

A generalized phase diagram is shown in Figure 1 for a binary system that has an upper critical solution temperature, TUCS.
Four equilibrium regions can be identified in the generalized phase diagram, i.e., one liquid region (in white), one liquid–liquid equilibrium region (LLE, in light green) and two solid–liquid equilibrium regions (SLE-I and SLE-II, in sky blue and lavender, respectively). The SLE-I region is bordered on the left by the solubility curve of Component B. Surrounded by a binodal (bold red curve), the LLE region sits on top of the SLE-I region. When the mixture composition falls between XB1 and XB2, one solid phase and two liquid phases can coexist at the temperature TSLL. For APIs with high melting points, e.g., osanetant (128.0 °C) [14], γ-aminobutyric acid (203.7 °C) [15] and β-alanine (207.0 °C) [16], their LLE region is usually not accessible under usual crystallization conditions.
When a solution represented by Point a (filled circle) is cooled into the LLE region, it splits into two stable liquid phases represented by Point a1 and Point a1’ on the binodal. Point a1 and Point a1’ are connected by a bold, dashed tie-line. The composition of the two liquid phases will change continuously along the binodal curve as the dispersion is cooled further. Below TSLL, their compositions change to Point a2 and Point a2’, respectively, and the dispersion becomes meta-stable with respect to the prospective crystal–solution suspension. Further cooling may lead to spontaneous crystal nucleation in one or both liquid phases.
LLPS can also occur below XB1. When a solution with a composition represented by Point b (empty circle) is cooled below a submerged binodal, it will split into two liquid phases represented by Point b1 and Point b1’ on a submerged binodal [17]. The resulting dispersion is meta-stable with respect to the prospective crystal–solution suspension. Similarly, crystal nucleation may take place in one or both liquid phases if given sufficient time or further cooling.
Many experiments and simulations have been conducted to understand the origin of LLPS. The presence of impurities, solvent–solute interactions and the shape of the potential energy between API molecules all play a part in the occurrence of LLPS [18]. L-sodium glutamate will cause LLPS in the crystallization of γ-aminobutyric acid when its concentration is greater than 2.0 wt% [15]. An amphiphilic molecule could crystallize normally in single-component solvents but switching to a water/methanol mixture leads to LLPS [17]. Simulation has revealed that LLPS will occur when the range of molecular attraction is sufficiently smaller than molecule size [19].

3. Experimental

Chemicals. Ibuprofen was obtained from the Hubei Biocause Heilen Pharmaceutical Co. Ltd. (Jingmen, China) and it was used as is without further purification. Absolute ethanol (>99.7%) was purchased from VWR Chemicals. Deionized water was also used.
Measurement procedure for the kinetic phase diagram. Clear points and cloud points of ibuprofen in ethanol/water mixtures were measured by slow heating and slow cooling methods in Crystalline®, wherein dissolution and precipitation/LLPS processes can be monitored by transmissivity. Samples were prepared with a known composition of ibuprofen, water, and ethanol. They were heated to a sufficiently high temperature to dissolve all ibuprofen crystals (transmissivity reached 100%). Then, the samples were cooled slowly at 0.1 °C/min until the temperature where the first drop in transmissivity was observed. This was recorded as the cloud point. Then, the samples were heated slowly at 0.1 °C/min until the transmissivity reached 100% and the temperature was recorded as the clear point. Two cycles of cooling–heating were conducted for every sample to obtain an average of two clear points and an average of two cloud points. The decrease in the transmissivity of a clear solution during cooling may be caused by either crystal nucleation or LLPS. The real cause was determined by particle vision measurement (PVM) during subsequent crystallization experiments.
Procedure for crystallization experiments. Crystallization was mainly carried out in a 500 mL jacketed vessel with a flat bottom, as shown in Figure 2a. The crystallizer was fitted with an overhead stirrer set at 300 rpm. The temperature was controlled by a circulating bath (Julabo FP50). The occurrence of LLPS and crystal morphology was monitored using a PVM (model V819 from Mettler Toledo, Columbus, OH, USA).
PVM images. Four representative PVM images are presented in Figure 2. Figure 2b is an image of when LLPS took place and it can be seen that the PVM probe window was covered with oil droplets. Figure 2c was taken when nucleation occurred in the presence of LLPS. Figure 2c is an image of seeds in the solution without LLPS, and Figure 2d is an image of seeds in the presence of LLPS.
In the experiments, three different ibuprofen concentrations in an ethanol/water mixture (50/50, v/v) were used, including 80, 100 and 140 mg/mL solvents. In each crystallization experiment, the mixture was heated to a temperature 5.0 °C higher than the corresponding clear point to obtain a clear solution. Then, the solution was cooled at a constant rate to 20.0 °C. After reaching 20.0 °C, the temperature was held constant for 60 min. Combinations of different seed loadings, cooling profiles and additions of surfactant were used to examine their effects on the crystallization process and crystal agglomeration. Crystals were harvested by filtration, followed by drying at room temperature overnight. The size and morphology of the crystals were observed under an optical microscope. Conditions for all crystallization experiments are listed in Table 1 for easy reference.

4. Results and Discussion

4.1. Kinetic Phase Diagram

The kinetic phase diagram of ibuprofen in ethanol/water mixtures (50/50, v/v) is shown in Figure 3.
The solid–liquid–liquid equilibrium temperature TSLL is around 35.0 °C with XB1 at around 120 mg/g solvent. A kinetic solubility curve can be obtained by fitting the clear points for ibuprofen concentration <120 mg/g solvent. The corresponding cloud points constitute the lower boundary of a meta-stable zone in the SLE region. The maximum ibuprofen concentration measured in this study was 160 mg/g solvent so only the left part of the LLE region is shown here. The clear points are close to their corresponding cloud points in the LLE region.
The positions of the starting solutions in different experiments are marked as red four-point stars in Figure 3 for easy reference. It can be seen that crystallization with a starting concentration of 80 and 100 mg/mL solvent will enter the SLE region after cooling, whereas crystallization with a starting concentration of 140 mg/mL solvent will fall in the LLE region.

4.2. Effects of Solute Concentration on Crystal Agglomeration in Unseeded Crystallization

Three unseeded crystallization experiments (Experiments 1, 2 and 3 as indicated in Table 1 and Figure 3) were conducted with a starting concentration of 80, 100 and 140 mg/g solvent, respectively. The cooling rate for these three experiments was set at 0.1 °C/min, with starting temperatures of 37.0, 40.0 and 45.0 °C, respectively, to the same final temperature of 20.0 °C. The three starting temperatures were chosen to ensure that all experiments began from homogeneous solutions.
With a starting concentration of 80 mg/g solvent, nucleation was observed at 24.0 °C without the occurrence of LLPS. When the starting concentration was increased to 100 mg/g solvent, LLPS was observed at 30.0 °C. Nucleation did not take place during the cooling period but happened during the holding stage at 20.0 °C. With a starting concentration of 140 mg/g solvent, the solution underwent LLPS at 42.0 °C. Similar to the case of 100 mg/g solvent, nucleation did not take place until the holding stage at 20.0 °C. It is not known whether nucleation started first in the oil droplets or in the continuous phase. During LLPS, the solute gets enriched in the oil phase at the expense of the other phases through uphill diffusion in spinodal decomposition [20]. The mass transfer is driven by the difference in the chemical potential of solute between two phases. As LLPS proceeds, the two liquid phases get closer in chemical potential and, thus, have a similar driving force for crystal nucleation.
The microscopic images of crystals obtained from these three experiments are shown in Figure 4. For a starting concentration of 80 mg/g solvent, unseeded crystallization produced a mixture of individual crystals and agglomerates, as Figure 4a displays. At the same time, higher starting concentrations (100 and 140 mg/g solvent) yielded agglomerates only. The agglomerates have irregular morphology and the constituent primary particles are thin plates as shown in Figure 4d.
The higher degree of agglomeration in Figure 4b,c can be attributed to the massive nucleation that occurred at a high supersaturation and the occurrence of LLPS. As mentioned earlier, nucleation took place at 20 °C in these two experiments, whereas the saturation temperature was 40 °C and 45 °C in Experiments 2 and 3, respectively. Such a high undercooling induced massive nucleation, producing a lot of small particles that are prone to aggregation. Meanwhile, the high supersaturation promoted crystal growth at the contact points between the primary particles in the aggregates, which would cement the primary particles together.
In quiescent or gently stirred solutions, oil droplets afford a series of separate spherical micro-vessels for crystal nucleation and growth. Nucleation and the subsequent growth therein produce monodispersed spherical agglomerates [14,17]. However, nucleation seemed to take place in both phases in this study, as Figure 2c indicated, since particles could be found inside and outside oil droplets. In stirred tanks such as the one used in this study, oil droplets possibly serve as bridging agents that promote the agglomeration of small particles [21]. Furthermore, the frequent coalescence and tearing up of droplets due to collisions between one another and with the impeller renders the agglomerate a non-spherical shape.

4.3. Secondary LLPS of the Oil Phase and Continuous Phase under Supercooling

The two liquid phases in the LLE region have different compositions and densities. They become supersaturated after they are cooled to below TSLL. Their response to supercooling has not been reported. To examine their behavior, 300 mL of the ibuprofen solution in the ethanol/water mixture (50/50, v/v) was prepared with a concentration of 140 mg/g solvent. It was heated to 45.0 °C for complete dissolution and then slowly cooled to 33.0 °C under agitation. LLPS occurred at around 42.0 °C. At 33.0 °C, the overhead stirrer was stopped, and the oil droplets were allowed to coalesce, forming two distinct liquid phases. The two phases were collected and stored separately. Around 50 mL of the top liquid layer (oil phase) was collected, and the remaining 250 mL was the denser continuous phase.
The clear and cloud points of each liquid phase were measured by the slow heating and cooling of 50 mL of each phase separately at 0.1 °C/min. PVM was used to monitor the process. The procedures were repeated, and the average values of the clear point, cloudy point and nucleation point were obtained. The results are tabulated in Table 2.
The oil phase and the continuous phase became homogeneous at 38.8 and 36.9 °C, respectively. When they were cooled, LLPS was observed at 37.7 °C in the oil phase and at 36.2 °C in the continuous phase, which was very close to their respective clear points. LLPS results from the minimization of the Gibbs free energy via uphill diffusion. When the primary oil phase is dispersed in the continuous phase as the droplets did in Experiment 3, the Gibbs free energy can be minimized via mass transfer across the large interfaces, with the effect that oil droplets become more concentrated in solute whereas the continuous phase becomes leaner, with each phase remaining homogeneous.
In unseeded crystallization with a starting ibuprofen concentration of 140 mg/g solvent (Experiment 3), nucleation did not take place after LLPS during the cooling stage. However, when the oil phase and continuous phase were cooled separately, nucleation happened at 26.2 °C in the former and at 26.9 °C in the latter. Delayed nucleation in Experiment 3 may be related to the continued mass transfer between the oil phase and the continuous phase, which lowered the chemical potential of solute and, thus, the driving force for crystal nucleation in Experiment 3.

4.4. Effects of Seeding and Cooling Profiles on Agglomeration

To mitigate agglomeration, 1 wt% seeds were added to each of the next four crystallization experiments (Experiments 4–7). Operating parameters for the four experiments can be found in Table 1 and Figure 5. The starting concentration in these four experiments was 80, 100, 140, and 140 mg/g solvent, respectively. The cooling rate was set at 0.1 °C/min in all experiments, with the initial temperature at 37.0, 40.0, 45.0, and 45.0 °C, and the seeding temperature at 30.0, 33.0, 33.0, and 33.0 °C, respectively. The solutions were slightly supersaturated when seeds were added so they did not dissolve. In Experiments 4 and 5, seeds were added before spontaneous nucleation or LLPS. In Experiments 6 and 7, seeds were added after LLPS took place.
In Experiments 4 to 6, the solution was constantly cooled from the initial temperature to 20.0 °C. In Experiment 7, the dispersion was held at 33.0 °C for 75 min after seed application, and then cooling was resumed. PVM showed that after the holding period, the oil droplets disappeared.
The images of the crystals harvested from the four experiments are shown in Figure 6. With starting concentrations of 80 and 100 mg/g solvent, seeded crystallization produced neat crystals of uniform size with little agglomeration. Seeds provide active surfaces on which solute molecules can deposit at a relatively low supersaturation. For these two starting concentrations, the seed loading of 1 wt% seemed sufficient at the cooling rate of 0.1 °C/min to avoid supersaturation build-up, which suppressed secondary nucleation and LLPS. PVM confirmed that LLPS did not take place at all for the starting concentration of 100 mg/g solvent.
For the starting concentration of 140 mg/g solvent, constant cooling still produced agglomerates and a sizeable fraction of small particles, as Figure 6c shows. The primary particles in these agglomerates are much bigger and thicker than those in Figure 4c. The primary particles of agglomerates are arranged in a radiating manner from a common core. The PVM image in Figure 2e revealed that seeds tend to be attracted by oil droplets, suggesting a possible mechanism as follows: Seeds were dispersed into small clusters around oil droplets. Each seed grew separately by consuming solute molecules inside and outside the host droplet. However, there were not sufficient seed surfaces for solute molecules to deposit on at a rate that matched the generation rate of the supersaturation in the early stage of cooling. Thus, the built-up supersaturation led to the secondary nucleation and agglomeration of growing seeds.
In addition, the mass transfer from the continuous phase to the oil phase (uphill diffusion) might still go on with continued cooling, i.e., the oil droplets became replete with solute molecules over time. In this way, the oil droplets lasted for a lengthened period of time, allowing the agglomeration of growing seeds around them.
With a temperature holding stage in the cooling profile of Experiment 7, the agglomeration and the fraction of small particles were reduced greatly (Figure 6d). The holding stage gave seeds sufficient time to consume solute molecules in both phases at a low supersaturation. The supersaturation can be estimated from the kinetic phase diagram (Figure 3). The solid–liquid–liquid equilibrium temperature TSLL was around 35.0 °C. At the seeding temperature of 33.0 °C, the supersaturation measured in the temperature difference can be estimated as 2.0 °C. At this supersaturation, crystal growth was sustained without nucleation being induced.

4.5. Use of Surfactant

Surfactants can change the surface tension of oil droplets and affect LLPS. They may also change the size of oil droplets. A dispersion with larger droplets can produce more nuclei than one with smaller droplets [22]. As a preliminary study on the effects of surfactants, Experiments 8 and 9 were conducted with Tween 80 and HPMC added to the starting solutions, respectively. Using Experiment 3 as a control, the starting concentration was set at 140 mg/g solvent in Experiments 8 and 9. The concentration of surfactants was 0.5 wt% of the solvent. The mixture was heated to 48 °C to obtain a clear solution. Then it was cooled at 0.1 °C/min to 20.0 °C, followed by a holding stage at 20.0 °C for 60 min.
Remember that LLPS occurred at 42.0 °C and nucleation happened during the temperature holding stage at 20.0 °C without surfactant (Experiment 3). With Tween 80, the mixture turned completely cloudy at 44.5 °C. However, no nucleation was observed at the end of the experiment. With HPMC, the mixture turned cloudy once the HPMC was added at 48.0 °C. Nucleation was observed during the temperature holding stage at 20 °C and the crystal image is shown in Figure 7. Compared with Figure 4c, the particles obtained with the addition of HPMC were less agglomerated and had bigger primary crystals.
Although the cloud point is affected by the use of surfactants as this study shows, more research is needed to understand how surfactants influence the dynamics of LLPS and, in turn, nucleation and crystal growth. This knowledge can then be employed when addressing the issue of LLPS in pharmaceutical crystallization.

5. Conclusions

The liquid–liquid phase separation (LLPS) and crystallization behavior of ibuprofen in an ethanol/water mixture has been studied. The occurrence of LLPS depended on the starting concentration. In the presence of LLPS, crystallization produced highly agglomerated crystals. LLPS that occurred under the solubility curve in the polythermal phase diagram could be circumvented by seeding. Meanwhile, the LLPS originating in the liquid–liquid equilibrium region could not be avoided. The agglomeration of crystals could be mitigated by seeding. Moreover, seed ageing at a low supersaturation was very effective at reducing agglomeration in the presence of LLPS. The oil phase and continuous phase resulting from LLPS underwent LLPS again when they were cooled separately. Nucleation seemed to be enhanced by the separate cooling of these two phases. The use of surfactants led to changes in LLPS and crystallization. More systematic work needs to be done for a mechanistic understanding of surfactant effects. The findings and techniques in this study may be applicable to the crystallization of other APIs with relatively low melting points.

Author Contributions

Conceptualization, R.B.H.T. and Z.-Q.Y.; methodology and experimentation, W.H.L. and Z.-Q.Y.; writing—original draft preparation, W.H.L.; writing—review and editing, Z.-Q.Y. and P.S.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data, models, or codes that support the findings of this study are available from the corresponding authors upon reasonable request.

Acknowledgments

In this section, you can acknowledge any support given which is not covered by the author contribution or funding sections. This may include administrative and technical support, or donations in kind (e.g., materials used for experiments).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Yu, Z.-Q.; Zhang, F.-K.; Tan, R.B.H. Liquid–liquid phase separation in pharmaceutical crystallization. Chem. Eng. Res. Des. 2021, 174, 19–29. [Google Scholar] [CrossRef]
  2. Duffy, D.; Cremin, N.; Napier, M.; Robinson, S.; Barrett, M.; Hao, H.; Glennon, B. In situ monitoring, control and optimization of a liquid–liquid phase separation crystallization. Chem. Eng. Sci. 2012, 77, 112–121. [Google Scholar] [CrossRef]
  3. Kim, S.; Wei, C.; Kiang, S. Crystallization Process Development of an Active Pharmaceutical Ingredient and Particle Engineering via the Use of Ultrasonics and Temperature Cycling. Org. Process. Res. Dev. 2003, 7, 997–1001. [Google Scholar] [CrossRef]
  4. Gao, Z.; Altimimi, F.; Gong, J.; Bao, Y.; Wang, J.; Rohani, S. Ultrasonic Irradiation and Seeding To Prevent Metastable Liquid–Liquid Phase Separation and Intensify Crystallization. Cryst. Growth Des. 2018, 18, 2628–2635. [Google Scholar] [CrossRef]
  5. Parimaladevi, P.; Supriya, S.; Srinivasan, K. The role of ultrasound in controlling the liquid-liquid phase separation and nucleation of vanillin polymorphs I and II. J. Cryst. Growth 2018, 484, 21–30. [Google Scholar] [CrossRef]
  6. Lu, J.; Li, Y.-P.; Wang, J.; Li, Z.; Rohani, S.; Ching, C.-B. Study on the Oiling-out and Crystallization for the Purification of Idebenone. Org. Process. Res. Dev. 2012, 16, 442–446. [Google Scholar] [CrossRef]
  7. Li, K.; Wu, S.; Xu, S.; Du, S.; Zhao, K.; Lin, L.; Yang, P.; Yu, B.; Hou, B.; Gong, J. Oiling out and Polymorphism Control of Pyraclostrobin in Cooling Crystallization. Ind. Eng. Chem. Res. 2016, 55, 11631–11637. [Google Scholar] [CrossRef]
  8. Yang, H.; Chen, H.; Rasmuson, Å.C. Sandwich crystals of butyl paraben. CrystEngComm 2014, 16, 8863–8873. [Google Scholar] [CrossRef]
  9. Rashid, A.; White, E.T.; Howes, T.; Litster, J.D.; Marziano, I. Effect of Solvent Composition and Temperature on the Solubility of Ibuprofen in Aqueous Ethanol. J. Chem. Eng. Data 2014, 59, 2699–2703. [Google Scholar] [CrossRef]
  10. Svärd, M.; Gracin, S.; Rasmuson, Å.C. Oiling out or molten hydrate—liquid–Liquid phase separation in the system vanillin–water. J. Pharm. Sci. 2007, 96, 2390–2398. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. De Albuquerque, I.; Mazzotti, M. Influence of Liquid-Liquid Phase Separation on the Crystallization of L -Menthol from Water. Chem. Eng. Technol. 2017, 40, 1339–1346. [Google Scholar] [CrossRef]
  12. Zhang, F.; Shan, B.; Wang, Y.; Zhu, Z.; Yu, Z.-Q.; Ma, C.Y. Progress and Opportunities for Utilizing Seeding Techniques in Crystallization Processes. Org. Process. Res. Dev. 2021, 25, 1496–1511. [Google Scholar] [CrossRef]
  13. Tanaka, K.; Takiyama, H. Effect of Oiling-Out during Crystallization on Purification of an Intermediate Compound. Org. Process. Res. Dev. 2019, 23, 2001–2008. [Google Scholar] [CrossRef]
  14. Veesler, S.; Revalor, E.; Bottini, A.O.; Hoff†, C. Crystallization in the Presence of a Liquid−Liquid Phase Separation. Org. Process. Res. Dev. 2006, 10, 841–845. [Google Scholar] [CrossRef]
  15. Sun, M.; Du, S.; Yang, J.; Wang, L.; Gao, Z.; Gong, J. Understanding the Effects of Upstream Impurities on the Oiling-Out and Crystallization of γ-Aminobutyric Acid. Org. Process. Res. Dev. 2020, 24, 398–404. [Google Scholar] [CrossRef]
  16. Sun, M.; Du, S.; Chen, M.; Rohani, S.; Zhang, H.; Liu, Y.; Sun, P.; Wang, Y.; Shi, P.; Xu, S.; et al. Oiling-Out Investigation and Morphology Control of β-Alanine Based on Ternary Phase Diagrams. Cryst. Growth Des. 2018, 18, 818–826. [Google Scholar] [CrossRef]
  17. Bonnett, P.E.; Carpenter, K.J.; Dawson, S.; Davey, R.J. Solution crystallisation via a submerged liquid–liquid phase boundary: Oiling out. Chem. Commun. 2003, 2003, 698–699. [Google Scholar] [CrossRef] [PubMed]
  18. Asherie, N.; Lomakin, A.; Benedek, G.B. Phase Diagram of Colloidal Solutions. Phys. Rev. Lett. 1996, 77, 4832–4835. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Dumetz, A.C.; Chockla, A.M.; Kaler, E.W.; Lenhoff, A.M. Protein Phase Behavior in Aqueous Solutions: Crystallization, Liquid-Liquid Phase Separation, Gels, and Aggregates. Biophys. J. 2008, 94, 570–583. [Google Scholar] [CrossRef] [Green Version]
  20. Favvas, E.P.; Mitropoulos, A.C. What is spinodal decomposition&63. J. Eng. Sci. Technol. Rev. 2008, 1, 25–27. [Google Scholar]
  21. Wang, L.; Bao, Y.; Sun, Z.; Pinfield, V.J.; Yin, Q.; Yang, H. Investigation of Agglomeration in the Presence of Oiling Out in the Antisolvent Crystallization Process. Ind. Eng. Chem. Res. 2021, 60, 4110–4119. [Google Scholar] [CrossRef]
  22. Takasuga, M.; Ooshima, H. Control of Crystal Size during Oiling Out Crystallization of an API. Cryst. Growth Des. 2014, 14, 6006–6011. [Google Scholar] [CrossRef]
Figure 1. Polythermal diagram of a binary mixture of Components A (solvent) and B (solute). The melting point of Component B is TMB.
Figure 1. Polythermal diagram of a binary mixture of Components A (solvent) and B (solute). The melting point of Component B is TMB.
Crystals 11 01326 g001
Figure 2. (a) Setup for crystallization experiments and representative PVM images; (b) when LLPS took place; (c) when nucleation took place in the presence of LLPS; (d) seeds in the solution without LLPS; (e) seeds in the presence of LLPS.
Figure 2. (a) Setup for crystallization experiments and representative PVM images; (b) when LLPS took place; (c) when nucleation took place in the presence of LLPS; (d) seeds in the solution without LLPS; (e) seeds in the presence of LLPS.
Crystals 11 01326 g002
Figure 3. Kinetic phase diagram of ibuprofen in ethanol/water mixtures (50/50, v/v). The positions of the starting solution are labelled as bold crosses.
Figure 3. Kinetic phase diagram of ibuprofen in ethanol/water mixtures (50/50, v/v). The positions of the starting solution are labelled as bold crosses.
Crystals 11 01326 g003
Figure 4. Microscopic images of ibuprofen crystals harvested from unseeded crystallization with starting concentrations of (a) 80, (b) 100 and (c) 140 mg/g solvent; (d) microscopic image of the primary particles in agglomerates at higher magnification than the previous three images. The scale bar stands for 100 µm.
Figure 4. Microscopic images of ibuprofen crystals harvested from unseeded crystallization with starting concentrations of (a) 80, (b) 100 and (c) 140 mg/g solvent; (d) microscopic image of the primary particles in agglomerates at higher magnification than the previous three images. The scale bar stands for 100 µm.
Crystals 11 01326 g004
Figure 5. Cooling profiles for seeded crystallization experiments with different starting ibuprofen concentrations (Experiments 4–7). Cooling rate set at 0.1 °C/min. Seeding points were marked by filled red circles. The two red circles for Experiments 6 and 7 overlapped.
Figure 5. Cooling profiles for seeded crystallization experiments with different starting ibuprofen concentrations (Experiments 4–7). Cooling rate set at 0.1 °C/min. Seeding points were marked by filled red circles. The two red circles for Experiments 6 and 7 overlapped.
Crystals 11 01326 g005
Figure 6. Effects of the starting concentration and temperature profile on agglomeration with a cooling rate of 0.1 °C/min and 1 wt% seed loading; (a) 80 mg/g solvent and constant cooling; (b) 100 mg/g solvent and constant cooling; (c) 140 mg/g solvent and without seed ageing; (d) 140 mg/g solvent with seed ageing.
Figure 6. Effects of the starting concentration and temperature profile on agglomeration with a cooling rate of 0.1 °C/min and 1 wt% seed loading; (a) 80 mg/g solvent and constant cooling; (b) 100 mg/g solvent and constant cooling; (c) 140 mg/g solvent and without seed ageing; (d) 140 mg/g solvent with seed ageing.
Crystals 11 01326 g006
Figure 7. Crystals obtained in the unseeded crystallization with HPMC.
Figure 7. Crystals obtained in the unseeded crystallization with HPMC.
Crystals 11 01326 g007
Table 1. Experimental conditions of crystallization.
Table 1. Experimental conditions of crystallization.
Experiment No.Cstart, mg/mL SolventTstart, °CCooling Rate, °C/minTseeding, °CSeed Loading, wt%
18037.00.1N.A.0.0
210040.00.1N.A.0.0
314045.00.1N.A0.0
48037.00.130.01.0
510040.00.133.01.0
614045.00.133.01.0
7 *14045.00.133.01.0
8 #14048.00.1N.A.0.0
9 ^14048.00.1N.A.0.0
Cstart, start concentration of ibuprofen; Tstart, starting temperature of cooling profiles; Tseeding, seeding temperature; *, the temperature was held at 33.0 °C for 75 min in Experiment 7; #, surfactant Tween was added in Experiment 8; ^, surfactant HPMC was added in Experiment 9.
Table 2. The behavior of two liquid phases under supercooling.
Table 2. The behavior of two liquid phases under supercooling.
Temperature, °COil PhaseContinuous Phase
Clear point38.836.9
Cloud point37.736.2
Nucleation point26.226.9
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lin, W.H.; Yu, Z.-Q.; Chow, P.S.; Tan, R.B.H. The Crystallization of Active Pharmaceutical Ingredients with Low Melting Points in the Presence of Liquid–Liquid Phase Separation. Crystals 2021, 11, 1326. https://0-doi-org.brum.beds.ac.uk/10.3390/cryst11111326

AMA Style

Lin WH, Yu Z-Q, Chow PS, Tan RBH. The Crystallization of Active Pharmaceutical Ingredients with Low Melting Points in the Presence of Liquid–Liquid Phase Separation. Crystals. 2021; 11(11):1326. https://0-doi-org.brum.beds.ac.uk/10.3390/cryst11111326

Chicago/Turabian Style

Lin, Wei Han, Zai-Qun Yu, Pui Shan Chow, and Reginald Beng Hee Tan. 2021. "The Crystallization of Active Pharmaceutical Ingredients with Low Melting Points in the Presence of Liquid–Liquid Phase Separation" Crystals 11, no. 11: 1326. https://0-doi-org.brum.beds.ac.uk/10.3390/cryst11111326

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop